Clinical Trial Update: Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study evaluating XELIRI/FOLFIRI plus simvastatin followed by simvastatin maintenance in metastatic colorectal cancer; the cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Capecitabine (Xeloda) (Capecitabine)
• Irinotecan (Camptosar) (Irinotecan)
• Leucovorin (folinic acid)
• Simvastatin (Zocor) (simvastatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN